Central Nervous System Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the central nervous system deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of 811 central nervous system deals from 2020 to 2025.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of central nervous system dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in central nervous system dealmaking.
Chapter 3 covers the financial deal terms for deals signed in the central nervous system field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.
Chapter 4 provides a review of the top 25 most active biopharma companies in central nervous system dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive and detailed review of central nervous system deals signed and announced since 2020 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of central nervous system deals listed by therapeutic target.
The report also includes numerous table and figures that illustrate the trends and activities in central nervous system deal making since 2020.
In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Central Nervous System Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.
Fully revised and updated, the report provides details of 811 central nervous system deals from 2020 to 2025.
The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of collaboration and licensing deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of central nervous system dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in central nervous system dealmaking.
Chapter 3 covers the financial deal terms for deals signed in the central nervous system field with stage of development announced. Deals are listed and sectioned by headline value, upfront payment, milestone payment and royalty rates.
Chapter 4 provides a review of the top 25 most active biopharma companies in central nervous system dealmaking. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive and detailed review of central nervous system deals signed and announced since 2020 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.
Chapter 6 provides a comprehensive directory of central nervous system deals listed by therapeutic target.
The report also includes numerous table and figures that illustrate the trends and activities in central nervous system deal making since 2020.
In addition, a comprehensive deal directory is provided organized by company A-Z and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Central Nervous System Collaboration and Licensing Deals provides the reader with the following key benefits:
- Understand deal trends since 2020
- Browse central nervous system collaboration and licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report Scope
Central Nervous System Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of central nervous system trends and structure of deals entered into by leading biopharma companies worldwide.Central Nervous System Collaboration and Licensing Deals includes:
- Trends in central nervous system dealmaking in the biopharma industry
- Overview of collaboration and licensing deal structure
- Directory of central nervous system deal records covering pharmaceutical and biotechnology
- The leading central nervous system deals by value
- Most active central nervous system licensing dealmakers
In Central Nervous System Collaboration and Licensing Deals, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
Central Nervous System Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the precise rights granted or optioned?
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Chapter 1 - Introduction
Chapter 2 - Trends in central nervous system dealmaking
Chapter 3 - Financial deal terms for central nervous system partnering
Chapter 4 - Leading central nervous system deals and dealmakers
Chapter 5 - Central nervous system contract document directory
Chapter 6 - Central nervous system dealmaking by therapeutic target
Deal Directory
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3E Bioventures Capital
- 4B Technologies
- 4D Molecular Therapeutics
- 4D Pharma
- 4E Therapeutics
- 23andMe
- A*STAR’ Institute of Molecular and Cell Biology
- Aachen University
- Aardvark Therapeutics
- Aarhus University Hospital
- Abbvie
- AbFero Pharmaceuticals
- Abilita Therapeutics
- ABL Bio
- Abliva
- ACADIA Pharmaceuticals
- Acasti Pharma
- Accelero Biostructures
- ACEA Therapeutics
- Acelrx Pharmaceuticals
- Aclarion
- Aclipse Therapeutics
- ACROBiosystems
- Actimed Therapeutics
- Acturum Life
- Aculys Pharma
- AcuraStem
- Adalvo
- Adamas Pharmaceuticals
- Addex Therapeutics
- Adhera Therapeutics
- Adimune
- Adolore Biotherapeutics
- Advanced Biological Laboratories
- ADx NeuroSciences
- AffaMed Therapeutics
- Affilogic
- Affinia Therapeutics
- AFT Pharmaceuticals
- AgeX Therapeutics
- Aguettant
- Aidoc
- Aiforia Technologies
- AimedBio
- Aitia
- Akome Biotech
- Alamar Biosciences
- Alberta Health Services
- Albert Einstein College of Medicine
- Alchemab Therapeutics
- Alcyone Therapeutics
- Alector
- Alectos Therapeutics
- Alexander Shulgin Research Institute
- Alexion Pharmaceuticals
- Alex Therapeutics
- Algernon Pharmaceuticals
- Aliada Therapeutics
- Aligning Science Against Parkinson’s
- Alkem Laboratories
- Allay Therapeutics
- Allen Institute for Brain Science
- Alligator Bioscience
- Alloy Therapeutics
- Alora Pharmaceuticals
- Alpha Cognition
- ALS Association
- AltaML
- Altasciences
- Altoida
- Alto Neuroscience
- Alume Biosciences
- AlzeCure Pharma
- Alzheimer's Drug Discovery Foundation
- Amarna Therapeutics
- Amathus Therapeutics
- Ambiopharm
- American National Multiple Sclerosis Society
- Amgen
- Amneal Pharmaceuticals
- AmplifyBio
- Amydis
- Amylyx Pharmaceuticals
- Andelyn Biosciences
- Angelini Pharma
- Anima Biotech
- Annogen
- Annovis Bio
- Antibe Therapeutics
- Apellis Pharmaceuticals
- Apic Bio
- Aposense
- Apotex
- AppliedVR
- AprilBio
- APRINOIA Therapeutics
- APST Research
- Aptinyx
- Aptorum Group
- Aqilion
- Aquestive Therapeutics
- Aquinnah Pharmaceuticals
- Aragen Life Sciences
- Arbor Biotechnologies
- Argobio
- Arrowhead Pharmaceuticals
- ARScience Biotherapeutics
- ARS Pharmaceuticals
- Artiria Medical
- Artizan Biosciences
- Asahi Intecc
- Asahi Kasei
- Ascidian Therapeutics
- Ashvattha Therapeutics
- Aspen Neuroscience
- Assertio Therapeutics
- Association for Frontotemporal Degeneration
- Astellas Pharma
- Astex Pharmaceuticals
- AstraZeneca
- Astrogen
- ATAI Life Sciences
- Atalanta Therapeutics
- Atara Biotherapeutics
- Athena GTX
- Athinoula A Martinos Center for Biomedical Imaging
- Athletic Heart Cardiac and Metabolic Testing
- Aurora Spine
- Autifony Therapeutics
- Autobahn Therapeutics
- Autonomix Medical
- Autotelic
- Avalon Action Alliance
- AviadoBio
- Avicanna
- Avicenna Technology
- Axcelead Drug Discovery Partners
- Axial Biotherapeutics
- Axoltis Pharma
- Axsome Therapeutics
- Barrow Neurological Institute
- Base4 Biotechnology
- Baszucki Brain Research Fund
- Battelle
- Beacon Biosignals
- Beam Therapeutics
- Beijing InnoCare Pharma
- Belay Diagnostics
- Belharra Therapeutics
- BenevolentAI
- Benuvia Therapeutics
- Beth Israel Deaconess Medical Center
- Bexson Biomedical
- Bial
- BigHat Biosciences
- BioArctic AB
- biOasis Technologies
- BioAxone BioSciences
- Biobeat
- Biocept
- BioCircuit Technologies
- Biocytogen
- BioDelivery Sciences
- Biofourmis
- Biogen
- Biohaven Pharmaceuticals
- Biolojic Design
- BioMarin Pharmaceutical
- Biomedical Advanced Research and Development Authority
- BioMed X Innovation Center
- BioNxt Solutions
- Bioqube Ventures
- Biorchestra
- BioRestorative Therapies
- Blackford
- Blackrock Microsystems
- Blackrock Neurotech
- Bloom Science
- BlueRock Therapeutics
- Blue Water Biotech
- Boehringer Ingelheim
- Boston University
- BPGbio
- BRAINBox Solutions
- Brain Canada
- BrainLAB
- Brainomix
- Brain Trauma Foundation
- Breakthrough Health
- Breath of Life International
- BridgeBio Pharma
- BridGene Biosciences
- Brigham and Women's Hospital
- Bright Minds Biosciences
- Bristol-Myers Squibb
- Broad Institute
- Broken String Biosciences
- Brown University
- Bruker
- BT BeaMedical Technologies
- C2N Diagnostics
- Cala Health
- California Institute for Regenerative Medicine
- CAMP4 Therapeutics
- Canadian Armed Forces
- Canadian Neuromuscular Disease Registry
- Cannassure Therapeutics
- Cannex Scientific
- Canon BioMedical
- Cantabio Pharmaceuticals
- Cap Alter Pharma
- Capsida Biotherapeutics
- Capsigen
- Captor Therapeutics
- Caraway Therapeutics
- Cardiff University
- Cardiovascular Solutions of Central Mississippi
- CareTaker Medical
- Carlsmed
- Carnegie Mellon University
- Case Western Reserve University
- Cassava Sciences
- Catalent
- Catalyst Pharmaceuticals
- Catholic University Leuven
- CC Biotechnology
- Cedars-Sinai Medical Center
- Celanese
- Celeri Health
- Cellectricon
- Cellenkos
- Cellerys
- Cellevolve Bio
- Cell X Technologies
- CenSyn
- Centogene
- Century Therapeutics
- Cerecin
- Cerecor
- Cerevel Therapeutics
- Cerveau Technologies
- Charite Universitatsmedizin Berlin
- Charles River Laboratories
- Chemify
- Chemomab Therapeutics
- Chiesi Global Rare Diseases
- Children's Hospital at Montefiore
- Children's Hospital Boston
- Chromocell
- Chugai Pharmaceutical
- Ciitizen
- Cincinnati Children’s Hospital Medical Center
- Cipla
- Citizens United for Research in Epilepsy
- CK Rizeon
- Clario
- Clearmind Medicine
- ClearPoint Neuro
- Clearsky Medical Diagnostics
- Cleave Therapeutics
- Clene Nanomedicine
- Cleveland Clinic
- Clexio
- CliniFusion
- Clintrex Research
- CMT Research Foundation
- CND Life Sciences
- CNX Therapeutics
- Coave Therapeutics
- CODA Biotherapeutics
- Code Biotherapeutics
- Codiak BioSciences
- Cognition Therapeutics
- Cohen Veterans Bioscience
- Collegium Pharmaceuticals
- Columbia University
- CombiGene
- Complix
- Complutense University of Madrid
- Concentric Analgesics
- Confo Therapeutics
- Contera Pharma
- Contineum Therapeutics
- Coya Therapeutics
- CraniUS
- Creative Medical Technologies
- CRISPR Therapeutics
- Cristalia
- Critical Path Institute (C-Path)
- Crossject
- CrossLink Bioscience
- CSL
- Curavit Clinical Research
- Curebase
- Cure Genetics
- CURE Pharmaceutical
- Cureverse
- Curexo
- Cyclica
- Cynergi Health Partners
- Cyntar Ventures
- D&D Pharmatech
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Danaher
- DAVI II Farmaceutica
- Defender Pharmaceuticals
- Defense Advanced Research Projects Agency
- Defense Health Agency (US)
- Delix Therapeutics
- Denali Therapeutics
- Department of Defense
- Department of Veterans Affairs
- Dewpoint Therapeutics
- DiagnaMed
- Diagnostic Biochips
- Diagnostic Robotics
- DiamiR
- Digestome Therapeutics
- DiscGenics
- doc.ai
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Duke University
- Dyno Therapeutics
- DZNE German Center for Neurodegenerative Diseases
- Eagle Pharmaceuticals
- eCential Robotics
- Echolight Medical
- EditForce
- Eikonizo Therapeutics
- Eikonoklastes Therapeutics
- Eikon Therapeutics
- Eisai
- ElectroCore
- Eli Lilly
- EmbodyBio
- Emerald Innovations
- EmergeOrtho
- Emory University
- Enable Injections
- Enamine
- Encoded Therapeutics
- Endo International
- Endopure Life Sciences
- Enigma Biomedical
- Ensysce Biosciences
- Enterin
- Entos Pharmaceuticals
- Envisagenics
- EpicGenetics
- Epilepsy Canada
- Epilepsy Foundation (EF)
- Equilibre BioPharmaceuticals
- Erasmus University Medical Center
- ERS Genomics
- Esteve
- ES Therapeutics
- ESYA Labs
- EtectRx
- Eterna Therapeutics
- Ethypharm
- EuMentis Therapeutics
- Eureka Eurostars
- Eurofarma
- European Innovation Council
- European Union
- Eversana
- EverythingALS Open Innovation Consortium
- Evolution Research Group
- Evonik Industries
- Evotec
- Exagen Diagnostics
- Exeltis
- Expesicor
- Expressive Neuroscience
- Exscientia
- Eyam Vaccines and Immunotherapeutics
- Facial Pain Research Foundation
- FAR Biotech
- Ferrer
- FightMND
- Find Therapeutics
- Firefly Neuroscience
- Florida Atlantic University Research
- Fondazione Telethon
- Food and Drug Administration (FDA)
- Forge Biologics
- Formosa Pharmaceuticals
- Foundation to Fight H-ABC
- Frametact
- Francis Crick Institute
- FreeMind Group
- FUJIFILM Cellular Dynamics
- Fujirebio Diagnostics
- Fundacion Progreso y Salud
- Fuzionaire Diagnostics
- Gain Therapeutics
- GB Sciences
- GE Healthcare
- GEMMA Biotherapeutics
- Gen
- GeneCode
- GenEdit
- GeneDX
- Genentech
- GeneQuantum Healthcare
- General Genomics
- Genetika+
- Geneva Foundation
- Genomoncology
- Genpharm
- Gensaic
- Genzyme
- Georgetown University
- Glysious
- Goldfinch Bio
- GoodRx
- Graviton Bioscience
- Grunenthal
- GSK
- GTx
- Guangzhou Fermion Technology
- H1
- Hadassah Brain Labs Center
- Hadassah Medical Center
- Hainan Sihuan Pharmaceutical
- Haisco Pharmaceutical
- Halberd
- HanAll Biopharma
- HanAll Pharmaceuticals
- Hangzhou Highlightll Pharmaceutical
- Happify Health
- Harbour Biomed
- Harmonic Bionics
- Healint
- Helius Medical Technologies
- Helsinn Birex Pharmaceuticals
- Hemostemix
- Herantis
- Heron Therapeutics
- Hetero Labs
- Higgs Boson Health
- Hikma Pharmaceuticals
- HonorHealth
- Hospital Fondation Adolphe de Rothschild
- Hospital for Special Surgery
- Hyloris Pharmaceuticals
- Hyperfine Research
- IACTA Pharmaceuticals
- IAMA Therapeutics
- IBM
- Icagen
- Icometrix
- Idorsia
- IIT-Istituto Italiano di Tecnologia
- Iktos
- Imeka
- Immuneering
- Immune Therapeutics
- Impel NeuroPharma
- Inagene Diagnostics
- INBRAIN Neuroelectronics
- Incannex Healthcare
- Incyte
- Indegene Lifesystems
- Inhibikase Therapeutics
- INmune Bio
- INNERVIA Bioelectronics
- Innodem Neurosciences
- Innosuisse
- Inscopix
- InSightec
- Insilico Medicine
- InSilicoTrials
- Insitro
- InspireMD
- Institute for Research in Biomedicine
- Institute for Research in Immunology and Cancer – Commercialization of Research
- Institute of Molecular and Clinical Ophthalmology Basel
- Institute of Neurodegenerative Diseases
- Integrated Micro-Chromatography Systems
- IntelGenx
- Inteligex
- Interaxon
- International Society of Heart and Lung Transplantation
- International Spine Study Group Foundation
- Intravacc
- Inventia Life Science
- Inventum Genetics
- Invitae
- Ionian University
- Ionis Pharmaceuticals
- Ipsen
- IRBM
- IRLAB
- Irras
- iRxReminder
- Ischemix
- Isosceles Pharmaceuticals
- Israeli National Authority for Technological Innovation
- iX Biopharma
- J2H Biotech
- JADBio
- JanOne
- Janssen Biotech
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Jazz Pharmaceuticals
- JCR Pharmaceuticals
- Jiangsu Aosaikang Pharmaceutical
- Jiangsu NHWA Pharmaceutical
- Jnana Therapeutics
- Johns Hopkins University
- Kahn-Sagol-Maccabi
- Karolinska Institute
- Karuna Therapeutics
- Kazia Therapeutics
- Keck School of Medicine of USC
- KeifeRx
- Keller Army Hospital
- Kessler Foundation
- KeyWise
- KIF1A
- Kindeva Drug Delivery
- Kineta
- Kira Pharmaceuticals
- Kissei Pharmaceutical
- Kit Check
- KK Women’s and Children’s Hospital
- Klaria
- Knopp Biosciences
- Koneksa Health
- Koru Medical Systems
- Kowa Pharmaceuticals America
- KT Corporation
- Kvantify
- Kymanox
- Kyverna Therapeutics
- Lacerta Therapeutics
- Landos Biopharma
- LANGaware
- Le Bonheur Children's Hospital
- Les Laboratoires Servier
- Liechti Lab
- Ligand Pharmaceuticals
- Lineage Cell Therapeutics
- Lipidomics Consulting
- Lipidor
- Lobe Sciences
- Lonza
- LoQus23 Therapeutics
- LTS Lohmann Therapie-Systeme
- Lucid Psycheceuticals
- Luciole Medical
- Lucy Therapeutics
- Lundbeck
- Lundquist Institute
- Lund University
- Lurie Children's Hospital of Chicago
- Luxna Biotech
- Lyfebulb
- Lysogene
- Lysosomal Therapeutics
- Maastricht University
- Mabylon
- MannKind Biopharmaceuticals
- Mapi Pharma
- MapLight Therapeutics
- Marinus Pharmaceuticals
- Maruishi Pharmaceutical
- MASORI Therapeutic
- Massachusetts General Hospital
- Mass General Brigham
- Mayo Clinic
- McGill University
- McMaster University
- McQuade Center for Strategic Research and Development
- MDimune
- Medical College of Wisconsin Neuroscience Institute
- Medical iSight
- Medical Product Laboratories
- Medical Research Council
- Medical University of Innsbruck
- Medical University South Carolina
- MediciNova
- Medidata Solutions
- Medipal Holdings
- MediPharm Labs
- MediSynergics
- Medolife Rx
- MedRhythms
- Medtronic
- Medvisis
- Melior Pharmaceuticals
- Menarini
- Merck and Co
- Merck KGaA
- Metabolon
- MetaSight Diagnostics
- Methodist Hospital Houston
- Metrion Biosciences
- MetVital
- Mi-Helper
- Michael J Fox Foundation
- Mid-Atlantic BioTherapeutics
- MiNA Therapeutics
- MindMaze
- Mind Medicine
- MindShift Compounds
- Minoryx Therapeutics
- Miravo Healthcare
- Mirimus
- Mitacs
- MitoCanada Foundation
- Mitochondrial Innovation Initiative
- Mitochon Pharmaceuticals
- MitoSense
- Mitsubishi Tanabe Pharma
- MOBILion Systems
- Modag
- Modalis Therapeutics
- Molecular Health
- Moleculera Labs
- Monte Rosa Therapeutics
- Montreal Neurological Institute-Hospital
- Motorpharma
- Motric Bio
- Movendo Technology
- MSD
- MThera Pharma
- Multiple Sclerosis Society of Canada
- Muscular Dystrophy Association
- Mylan Laboratories
- MYND Life Sciences
- Myrtelle
- Myung In Pharm
- n-Lorem Foundation
- NanoDx
- Nanoform
- NASA
- NATA
- National Center for Advancing Translational Sciences (NCATS)
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- National Institute on Drug Abuse (NIDA)
- National Institutes of Health
- National Organization for Rare Disorders
- National Resilience
- National University of Ireland
- Galway (NUI Galway)
- National Yang-Ming University
- Navamedic
- Negev Labs
- Nektar Therapeutics
- Neogap Therapeutics
- Neo Medical
- Neotope
- NervGen Pharma
- NE Scientific
- Nestle Health Science
- NetraMark
- NeuCyte
- Neumentum
- Neumora Therapeutics
- NeuPath Health
- NeuraLight
- Neuraly
- Neuramedy
- Neuraxpharm
- Neurelis
- Neurgain Technologies
- Neuro3 Therapeutics
- Neuro42
- NeuroBiogen
- NeuroBo Pharmaceuticals
- Neurochase
- Neurocrine Biosciences
- NeuroFront
- Neurogene
- NeuroGenesis
- Neurolief
- Neurolixis
- Neuron23
- Neuronasal
- Neurona Therapeutics
- NeuroNexus
- Neuronic
- NeuroOne
- NeuroPace
- Neuropore Therapies
- NeuroScience Associates
- NeuroSense Therapeutics
- NeuroSigma
- NeuroTrauma
- Newel Health
- Newly Institute
- Newron Pharmaceuticals
- Nico
- Nippon Shinyaku
- NKGen Biotech
- Noema Pharma
- North Med
- NorthShore University HealthSystem
- Northwestern University
- NovAccess Global
- Novaremed
- Novartis
- Noveome Biotherapeutics
- NRG Therapeutics
- Nuance Pharma
- Nuformix
- Numares
- NurExone Biologic
- Nurosene
- NurrOn Pharmaceuticals
- Nutriband
- NuVasive
- nView Medical
- NysnoBio
- NYU Langone Medical Center
- Oblique Therapeutics
- ObvioHealth
- Oculogica
- Ohio State Innovation Foundation
- Ohio State University
- Oklahoma Medical Research Foundation
- Olaris
- Olatec Therapeutics
- Oncotelic
- OncoZenge
- Onegevity
- Ono Pharmaceutical
- ONWARD Medical
- Orchard Therapeutics
- Organo Therapeutics
- Orion
- Orionis Biosciences
- Orphazyme
- Orthofix Medical
- Oryzon
- Oslo University Hospital
- Osmotica Pharmaceuticals
- Ovid Therapeutics
- Owl Therapeutics
- OWP Pharmaceuticals
- Oxyrane UK
- Pacific Biosciences
- PainQx
- Parkinson's Disease Foundation
- Parkinson's UK
- Parkinsons Disease Foundation
- Pasithea Therapeutics
- Passage Bio
- Pathway Rx
- Patient-Centered Outcomes Research Institute
- PEAR Therapeutics
- PECET
- PeptiDream
- Pfizer
- Pharmaleads
- Pharmanovia
- Pharmathen
- PharmaTher
- Pharma Two B
- Pharmazz
- PharmEnable
- Pheno Therapeutics
- Philips
- Phoenix PharmaLabs
- PhoreMost
- PicnicHealth
- PINC AI Applied Sciences
- Planet Green BioTechnology
- Plexium
- Plus Therapeutics
- Polyrizon
- Praxis Precision Medicines
- PreCerv
- PrecisionLife
- Prevail Therapeutics
- Primary Peptides
- Procaps
- Progentec Diagnostics
- Project ALS
- Propella Therapeutics
- Prothena
- Protxx
- Psilera
- PsychoGenics
- Psylo
- PTC Therapeutics
- Pulmatrix
- Purespring Therapeutics
- PurMinds NeuroPharma
- Q-Gen Cell Therapeutics
- Q30 Innovations
- QIAGEN
- Quadram Institute
- Quansys Biosciences
- Quantiphi
- Quebec Consortium for Drug Discovery
- Queensland Institute of Medical Research (QIMR)
- Quell Therapeutics
- Quotient
- QurAlis
- rAAVen Therapeutics
- Ractigen Therapeutics
- Rafa Laboratories
- Rainwater Charitable Foundation
- RBC Medical Innovations
- ReAlta Life Sciences
- Recro Pharma
- Recursion
- Redwire
- Regenacy Pharmaceuticals
- Regenerative Medicine of Latin America
- Regenexx
- Regulus Therapeutics
- Releviate Therapeutics
- Repertoire Immune Medicines
- RespireRx Pharmaceuticals
- RetroBrain
- RF Innovations
- Rgenta Therapeutics
- Rho
- Rhoshan Pharmaceuticals
- Rigel Pharmaceuticals
- Rigshospitalet
- Roche
- Rosalind Franklin University of Medical Sciences
- Rose F Kennedy Intellectual and Developmental Disabilities Research Center
- Rosies Base
- Roswell Biotechnologies
- Royal Philips Electronics
- Rune Labs
- Rutgers Cancer Institute of New Jersey
- Safe Orthopaedics
- Sage Therapeutics
- Saitama Medical University Hospital
- Salus Pharma
- Samsung Biologics
- Sandoz
- Sangamo Therapeutics
- Saniona
- Sanofi
- Santa Clara University
- Sarepta Therapeutics
- SATT Conectus Alsace
- Sawai Pharmaceuticals
- Schenker Technologies
- Schrodinger
- Scilex Holding
- Scilex Pharmaceuticals
- SciNeuro Pharmaceuticals
- Scipher Medicine
- SciSparc
- Scribe Therapeutics
- Sean M Healey & AMG Center for ALS
- Seattle Children's Therapeutics
- Secarna Pharmaceuticals
- Seed Therapeutics
- Seelos Therapeutics
- Selonterra
- Selvita
- Sengenics
- Sensome
- Senti Biosciences
- Seqirus
- SeraNovo
- SERB Pharmaceuticals
- Serina Therapeutics
- SFJ Pharmaceuticals
- Shanghai Accurature Diagnostics
- Shape Therapeutics
- Sheffield Institute for Translational Neuroscience
- Shina Systems
- Shionogi
- Shirley Ryan AbilityLab
- Sibylla Biotech
- Siemens Healthineers
- Silo Pharma
- Simcere Pharmaceuticals
- Sinopia Biosciences
- SipNose
- Sironax
- SiteOne Therapeutics
- SKAN Research Trust
- SK Biopharmaceuticals
- SK Chemicals
- Skye Bioscience
- Skyhawk Therapeutics
- SkyWater Technology
- Smithfield BioScience
- Society of NeuroInterventional Surgery
- Society of Vascular and Interventional Neurology
- Sonnet BioTherapeutics
- Sorrento Therapeutics
- Sosei Heptares
- Sovargen
- Spark Therapeutics
- Specialised Therapeutics
- Spectrum Spine
- Sperogenix Therapeutics
- Spineart
- SpineCraft
- Spinogenix
- Stanford University
- Starton Therapeutics
- Statera Biopharma
- State University of New York
- Stealth BioTherapeutics
- Stem Pharm
- Stevanato
- Stoke Therapeutics
- Stony Brook University
- Stratus Research Labs
- StrideBio
- Sumitomo Dainippon Pharma
- Sunnybrook Research Institute
- Sunovion Pharmaceuticals
- Sun Pharmaceutical
- SwanBio Therapeutics
- Swedish Orphan Biovitrum
- Swedish Research Council
- Swysh
- Synaffix
- Synaptogenix
- SynPhNe
- Tabuk Pharmaceuticals
- Takeda Pharmaceutical
- Target ALS Foundation
- Tautomer Bioscience
- Taysha Gene Therapies
- Teijin
- Temedica
- Tenacia Biotechnology
- Terran Biosciences
- Tetra Pharm Technologies
- Tetraphase Pharmaceuticals
- Teva Pharmaceutical Industries
- Tevard Biosciences
- TG Therapeutics
- The Cure Parkinson's Trust
- The New York Stem Cell Foundation
- Theradaptive
- Theranexus
- Theranica Bio-Electronics
- TheraPanacea
- Therapeutic Solutions International
- Therapix Bio
- Thomas Jefferson University
- TLC BioSciences
- TONIX Pharmaceuticals
- Total Brain
- Treeway
- Turn Biotechnologies
- Twist Bioscience
- Ubiquigent
- UCB
- UniQure
- University College London
- University Health Network
- University Medical Center Utrecht
- University of Alabama at Birmingham
- University of Alberta
- University of Arizona
- University of Auckland
- University of Barcelona
- University of Bath
- University of British Columbia
- University of Calgary
- University of California
- Davis
- University of California
- San Diego
- University of California Berkeley
- University of California Irvine
- University of California Riverside
- University of California San Francisco
- University of Chicago
- University of Copenhagen
- University of Edinburgh
- University of Florida
- University of Glasgow
- University of Helsinki
- University of Iowa
- University of Kentucky
- University of Leeds
- University of Lethbridge
- University of Marburg
- University of Maryland School of Medicine
- University of Massachusetts Medical School
- University of Memphis
- University of Miami
- University of Miami Miller School of Medicine
- University of Montreal
- University of Oxford
- University of Pennsylvania
- University of Pittsburgh
- University of Rochester Medical Center
- University of Rome
- University of Sheffield
- University of Sydney
- University of Texas Southwestern Medical Center
- University of Toronto
- University of Washington
- University of Wollongong
- Unlearn
- Unravel Biosciences
- Uppsala University
- US Army Medical Research and Material Command
- Valence Discovery
- Vanderbilt University
- Vandria
- Vastrax
- Vaxxinity
- Vect-Horus
- VectorY Therapeutics
- Vectura
- Veeva Systems
- Veltmeyer MD
- Ventus Therapeutics
- Verge Genomics
- VeriSIM Life
- Vernalis
- Vertex Pharmaceuticals
- Vesalius Therapeutics
- Vincere Biosciences
- Virginia Commonwealth University
- Virpax Pharmaceuticals
- Visiopharm
- VistaGen Therapeutics
- Vitruvias Therapeutics
- Viz.ai
- VoxNeuro
- Voyager Therapeutics
- Vyant Bio
- Vyripharm
- Wake Research Associates
- Walter Reed Army Institute of Research
- WAVE Life Sciences
- Weill Cornell Medical College
- Weizmann Institute
- Willow Biosciences
- Wisconsin Health Information Organization
- WraSer Pharmaceuticals
- Wren Therapeutics
- Wuxi Apptec Laboratory Services
- Wuxi STA
- Wyss Center
- X-chem
- Xspire Pharma
- Yale University
- Yeda Research and Development Company
- Yumanity Therapeutics
- Zambon
- Zelira Therapeutics
- Zentiva
- Zeta Surgical
- Zhittya Genesis Medicine
- Zhongze Therapeutics
- Zimmer Biomet
- Zogenix
- ZyVersa Therapeutics
- ZZ Biotech
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
